secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001437749-25-005911
Event type: earnings
Sentiment:  positive
Materiality: 0.72
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics reports record Q4 revenue $5.1M, net loss improves 25% for FY 2024
-------------------------------------------------------------------------------

- Q4 2024 revenue $5.1M, up 5% YoY; gross margin 53%, up 400 bps vs 49% in Q4 2023.
- FY 2024 revenue $17.9M, down 2% YoY; net loss $11.3M ($0.56/sh), 25% better than FY 2023.
- Cash and restricted cash $6.5M at Dec 31, 2024; operating cash burn improved to $9.8M from $12.1M.
- Post-year-end, named National Seating & Mobility exclusive U.S. distributor for Ekso Indego Personal device.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925005911/0001437749-25-005911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774925005911/ekso20241114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-005911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer